The Influence of Serum Homocysteine Level to the Prognosis of Newly Diagnosed Multiple Myeloma Patients and Analysis of Related Factors.
10.19746/j.cnki.issn.1009-2137.2021.02.035
- Author:
Yuan FU
1
;
Xiao-Fang WEI
1
;
You-Fan FENG
1
;
Fei LIU
1
;
Qiao-Lin CHEN
1
;
Yang-Yang ZHAO
1
;
Wen-Jie ZHANG
1
;
Ting MA
1
;
Xiu-Juan HUANG
1
;
Yang CHEN
1
;
Qing-Fen LI
1
;
Qi-Ke ZHANG
2
Author Information
1. Department of Hematology,Gansu Provincial Hospital,Lanzhou 730700,Gansu Province,China.
2. Department of Hematology,Gansu Provincial Hospital,Lanzhou 730700,Gansu Province,China,E-mail:zqk05@163.com.
- Publication Type:Journal Article
- MeSH:
Bone Marrow Cells;
Homocysteine;
Humans;
Multiple Myeloma;
Prognosis;
Risk Factors
- From:
Journal of Experimental Hematology
2021;29(2):530-534
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the influence of serum homocysteine (Hcy) levels to the prognosis of newly diagnosed multiple myeloma (MM) patients, and to explore related factors affecting the prognosis of the patients.
METHODS:The clinical pathological data of 180 newly diagnosed MM patients treated in our hospital from March 2013 to February 2015 were collected, and the patients were divided into high and low Hcy groups based on the median Hcy. The survival curves of the patients in the two groups were drawn to compare the differences of the survival; univariate and multivariate survival analysis was used to observe the influence of serum cysteine to the prognosis of newly diagnosed MM patients; the clinicopathological data of the patients with high and low Hcy in the two groups was compared, Pearson test was used to further analyzes the relationship between Hcy and different factors, and explores the related factors of Hcy affecting the prognosis of the patients.
RESULTS:The median survival times of patients in the high and low Hcy groups were 32 (5-59) and 41 (7-71) months, respectively. The 3-year survival rate of the patients in high Hcy group was significantly lower than those in low Hcy group, and the difference shows statistically significant (P<0.05). The results of univariate survival analysis showed that the OS of newly diagnosed MM patients whom with advanced age, high bone disease grade, high-level bone marrow plasma cell count, LDH, C-reactive protein, Cr, β
CONCLUSION:Serum Hcy level has a correlation trend with the survival of newly diagnosed MM, which is affected by factors such as Hb.
